Principal Street Partners, LLC Novo Nordisk A S Transaction History

Principal Street Partners, LLC

$534 Million
Q1 2025

A detailed history of Principal Street Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Principal Street Partners, LLC holds 9,513 shares of NVO stock, worth $670,095. This represents 0.12% of its overall portfolio holdings.

Number of Shares

9,513

Previous 9,278 2.53%

Holding current value

$670,095

Previous $1.1 Million 40.22%

% of portfolio

0.12%

Previous 0.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$69.3 - $90.95 $16,285 - $21,373	235 Added 2.53%	9,513 $660,000
Q3 2024 Nov 13, 2024	SELL	$119.07 - $145.42 $1,190 - $1,454	-10 Reduced 0.11%	9,278 $1.1 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $1,227 - $1,469	10 Added 0.11%	9,288 $1.33 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $151,224 - $201,297	-1,481 Reduced 13.77%	9,278 $1.19 Million
Q4 2023 Feb 07, 2024	SELL	$87.78 - $105.45 $944,425 - $1.13 Million	-10,759 Reduced 50.0%	10,759 $1.11 Million
Q3 2023 Nov 01, 2023	BUY	$90.94 - $199.54 $1.49 Million - $3.28 Million	16,433 Added 323.17%	21,518 $1.96 Million
Q2 2023 Aug 21, 2023	SELL	$155.98 - $172.65 $214,628 - $237,566	-1,376 Reduced 21.3%	5,085 $822,000
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $17,998 - $21,643	136 Added 2.15%	6,461 $1.03 Million
Q4 2022 Feb 15, 2023	BUY	$102.55 - $135.33 $11,690 - $15,427	114 Added 1.84%	6,325 $855,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $33,252 - $40,808	349 Added 5.95%	6,211 $619,000
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $119,655 - $141,177	-1,159 Reduced 16.51%	5,862 $653,000
Q1 2022 May 05, 2022	BUY	$93.1 - $112.54 $653,655 - $790,143	7,021 New	7,021 $787,000
Q4 2021 Feb 07, 2022	SELL	$95.88 - $117.08 $588,703 - $718,871	-6,140 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $121,649 - $153,639	1,441 Added 30.67%	6,140 $589,000
Q2 2021 Aug 10, 2021	BUY	$67.66 - $84.76 $22,327 - $27,970	330 Added 7.55%	4,699 $394,000
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $278,261 - $306,791	4,369 New	4,369 $303,000
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $360,021 - $417,831	-6,150 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $760 - $854	16 Added 0.26%	6,150 $318,000
Q2 2019 Aug 15, 2019	BUY	$46.79 - $52.47 $287,009 - $321,850	6,134 New	6,134 $313,000

Others Institutions Holding NVO

# of Institutions

1,768

Shares Held

330M

Call Options Held

11.3M

Put Options Held

15.5M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $159B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Street Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Principal Street Partners, LLC with notifications on news.

Account

Principal Street Partners, LLC Novo Nordisk A S Transaction History